Literature DB >> 6742598

Hermansky-pudlak syndrome and interstitial lung disease: report of a case with lavage findings.

D A White, G J Smith, J A Cooper, M Glickstein, J A Rankin.   

Abstract

Clinical and pathologic evidence for interstitial pulmonary fibrosis occurring in some patients with the Hermansky-Pudlak syndrome is well described in the literature, but data on immunologic mechanisms operating in this form of lung disease have not been published. In this case report, we describe bronchoalveolar lavage (BAL) findings in a patient with this syndrome. Recovered alveolar macrophages (AM) contained the characteristic ceroidlike material previously described in interstitial macrophages in pathologic specimens. The BAL analysis was similar to that seen in idiopathic pulmonary fibrosis, with increased levels of immunoglobulins and numbers of IgG and IgA secreting cells, and normal percentages of putative helper and suppressor T-cell subsets. In addition, superoxide production by stimulated AM was increased, possibly secondary to phagocytosis of the ceroidlike material. The lavage in this patient was compatible with a mild inflammatory process that was consistent with gallium scan results and the patient's clinical course.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6742598     DOI: 10.1164/arrd.1984.130.1.138

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome.

Authors:  Elena N Atochina-Vasserman; Sandra R Bates; Peggy Zhang; Helen Abramova; Zhenguo Zhang; Linda Gonzales; Jian-Qin Tao; Bernadette R Gochuico; William Gahl; Chang-Jiang Guo; Andrew J Gow; Michael F Beers; Susan Guttentag
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

2.  Ocular findings in the Hermansky-Pudlak syndrome.

Authors:  N J Izquierdo; W Townsend; I E Hussels
Journal:  Trans Am Ophthalmol Soc       Date:  1995

3.  Vision in albinism.

Authors:  C G Summers
Journal:  Trans Am Ophthalmol Soc       Date:  1996

4.  Lung-restricted macrophage activation in the pearl mouse model of Hermansky-Pudlak syndrome.

Authors:  Lisa R Young; Michael T Borchers; Holly L Allen; Reta S Gibbons; Francis X McCormack
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

5.  Diffuse pulmonary fibrosis and the Hermansky-Pudlak syndrome: clinical course and postmortem findings.

Authors:  S P Reynolds; B H Davies; A R Gibbs
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

Review 6.  Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics.

Authors:  Pamela Velázquez-Díaz; Erika Nakajima; Parand Sorkhdini; Ashley Hernandez-Gutierrez; Adam Eberle; Dongqin Yang; Yang Zhou
Journal:  Front Pharmacol       Date:  2021-03-18       Impact factor: 5.810

7.  CB1 R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky-Pudlak syndrome.

Authors:  Resat Cinar; Joshua K Park; Charles N Zawatsky; Nathan J Coffey; Steven P Bodine; Jasmina Abdalla; Tadafumi Yokoyama; Tony Jourdan; Lindsey Jay; Mei Xing G Zuo; Kevin J O'Brien; Junfeng Huang; Ken Mackie; Asaf Alimardanov; Malliga R Iyer; William A Gahl; George Kunos; Bernadette R Gochuico; May Christine V Malicdan
Journal:  Clin Transl Med       Date:  2021-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.